نتایج جستجو برای: triple therapy regimen

تعداد نتایج: 726117  

2012
Riccardo Urgesi Rossella Cianci Maria Elena Riccioni

With the rising prevalence of antimicrobial resistance, the treatment success of standard triple therapy has recently declined to unacceptable levels (ie, 80% or less). Following the failure of conventional triple therapy, novel eradication regimens have been developed including sequential therapy, concomitant quadruple therapy, hybrid (dual-concomitant) therapy, bismuth-containing quadruple th...

Journal: :European review for medical and pharmacological sciences 2008
G Scaccianoce A Zullo C Hassan F Gentili F Cristofari V Cardinale F Gigliotti D Piglionica S Morini

The Helicobacter pylori (H. pylori) cure rate following standard triple therapies is decreasing worldwide. Therefore, further approaches aimed to improve standard triple therapy efficacy should be attempted. This prospective, pilot study aimed to evaluate the therapeutic role of either Lactobacillus reuteri (L. reuteri) or a high concentration of probiotics in addition to standard triple therap...

Journal: :British journal of clinical pharmacology 1997
J G Penston K E McColl

The purpose of the present review was to determine objectively the optimal treatment for the eradication of H. pylori amongst the currently used regimens. A comprehensive literature search provided a data-base relating to the following treatments: dual therapy with an anti-secretory drug plus either amoxycillin or clarithromycin; standard triple therapy, with or without additional anti-secretor...

2016
Giuseppe Losurdo Floriana Giorgio Andrea Iannone Mariabeatrice Principi Michele Barone Alfredo Di Leo Enzo Ierardi

We read with interest the recent meta-analysis by Lin et al who evaluated the effectiveness of concomitant regimen for Helicobacter pylori (H. pylori) in Chinese regions. They found that 7-d concomitant regimen is undoubtedly superior to 7-d triple therapy (91.2% vs 77.9%, P < 0.0001). However, it is a common belief that a triple therapy lasting 7 d should be definitively removed from the clini...

2015
Martin J. Downes Emilie K. Bettington Jenny E. Gunton Erika Turkstra Susanne la Fleur

Aims. The purpose was to evaluate the evidence for triple therapy regimen using medicines available in Australia for type 2 diabetes. Methods. A systematic literature review was performed to update the relevant evidence from 2002 to 2014 on triple therapy for type 2 diabetes. A multiple-treatments network meta-analysis was undertaken to summarise the comparative efficacy and harms of different ...

Journal: :Internal medicine 2010
Yuan Wenzhen Li Yumin Guan Quanlin Yang Kehu Jiang Lei Wang Donghai Yang Lijuan

BACKGROUND With the wide use of antibiotics, antibiotic-resistant Helicobacter pylori strains are becoming increasingly prevalent. It has been hypothesized that culture-guided therapy might help to increase treatment success. But the effects and the costs still remain controversial. AIMS To systematically review the efficacy and the cost of culture-guided triple therapy, compared to standard ...

Journal: :Alimentary pharmacology & therapeutics 2000
B C Wong F Y Chang S Abid Z Abbas B R Lin C Van Rensburg P C Chen H Schneider A E Simjee S S Hamid A Seebaran J Zhang M Destefano S K Lam

BACKGROUND Studies assessing the efficacy of triple therapy containing clarithromycin and amoxicillin for the eradication of Helicobacter pylori infection and healing of duodenal ulcers in Asian and African countries are limited. AIM To determine the efficacy and safety of 1-week triple therapy with omeprazole, amoxicillin and clarithromycin for eradicating H. pylori infection in patients wit...

2017
Mahmoud Sadeghi-Hadad-Zavareh Seyyedsaeid Mohammadi Mahmoud Hajiahmadi Mostafa Javanian Masoomeh Habibian

BACKGROUND The rate of Helicobacter pylori (H.pylori) eradication in dyspeptic patients using bismuth- based triple therapy is low due to bacterial that are resistant to antibiotics. The results of recent studies regarding levofloxacin have been encouraging, but the high cost of treatment prevents its routine administration. We, therefore, performed the present double-blind clinical trial to co...

Journal: :Diabetic medicine : a journal of the British Diabetic Association 2009
A J Scheen M H Tan D J Betteridge K Birkeland O Schmitz B Charbonnel

AIMS We assessed the long-term glycaemic effects and the safety profile of triple therapy with the addition of pioglitazone vs. placebo in patients with Type 2 diabetes treated with combined metformin-sulphonylurea therapy in the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive). METHODS In a post-hoc analysis, we identified patients treated with metformin plus sulph...

Journal: :Alimentary pharmacology & therapeutics 2003
A Zullo D Vaira N Vakil C Hassan L Gatta C Ricci V De Francesco M Menegatti A Tampieri F Perna V Rinaldi F Perri C Papadìa F Fornari S Pilati L S Mete A Merla R Potì G Marinone A Savioli S M A Campo D Faleo E Ierardi M Miglioli S Morini

BACKGROUND Eradication rates of Helicobacter pylori with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. AIM To assess the eradication rate of a new sequential treatment regimen compared with conventional triple therapy for the eradication of H. pylori infection. METHODS One thousand and forty-nine dyspeptic patients were studied ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید